Multicenter, randomized, open-label phase II trial of two doses of interferon (IFN)-alpha 2b with didanosine (ddI) in HIV-related Kaposi's sarcoma: ACTG 206 Meeting Abstract


Authors: Krown, S. E.; Li, P.; Von Roenn, J.; Testa, M.
Abstract Title: Multicenter, randomized, open-label phase II trial of two doses of interferon (IFN)-alpha 2b with didanosine (ddI) in HIV-related Kaposi's sarcoma: ACTG 206
Meeting Title: 4th International AIDS Malignancy Conference
Journal Title: JAIDS: Journal of Acquired Immune Deficiency Syndromes
Volume: 23
Issue: 3
Meeting Dates: 2000 May 16-18
Meeting Location: Bethesda, MD
ISSN: 1525-4135
Publisher: Lippincott Williams & Wilkins  
Date Published: 2000-03-01
Start Page: A22
Language: English
ACCESSION: WOS:000086883600071
PROVIDER: wos
PUBMED: 10858077
Notes: Meeting Abstract: 32 -- Source: Wos
Citation Impact
MSK Authors
  1. Susan Krown
    156 Krown